Folate instead of folic acid: what sits behind MTHFR and methylation

You are sitting in front of a report you ordered yourself. It says: MTHFR C677T, heterozygous. Or homozygous. Underneath, a sentence about reduced enzyme activity.

And then you do what everyone does. You type the term into a search box. What comes back is a mix of biochemistry lecture and end of the world. Blocked detoxification. Disturbed methylation. Exhaustion, depression, miscarriages, all of it supposedly explained by this one swapped letter.

I understand the fascination. A gene that suddenly holds everything together is a seductive story. It gives a diffuse suffering a hard, biological address.

The story just does not sit well with the numbers. And the part that is genuinely relevant in practice often gets lost in the noise. So let us start at the beginning, with three words that keep getting mixed up.

One letter in a gene test, and suddenly it explains your whole life

Imagine someone tells you: you have a rare genetic peculiarity that slows down your metabolism. That sounds significant. It sounds like an explanation.

Now imagine someone tells you: roughly every third person in some populations has this peculiarity. Suddenly the same sentence sounds quite different.

That is exactly where the misunderstanding sits. The C677T polymorphism in the MTHFR gene is consistently called a mutation online. Medically, the word is off. A mutation is a rare deviation. What we have here is a common variant that has held its place in many populations over thousands of years.

A thought for placing it: very common gene variants rarely have a large effect on the individual person on average, otherwise they would stand out far more clearly in the clinic. That is a rule of thumb and not a law, there are exceptions. For the C677T variant it does fit well with what the large analyses show.

That does not mean the variant is irrelevant. At population level its effect can be measured cleanly. For you as a person it is one of many factors, and rarely the strongest.

And now you know why I start this topic with the biochemistry and not with the lab slip.

Folic acid, folate, 5-MTHF: three words, three different molecules

Almost every misunderstanding in this field comes from three terms being used as synonyms. They are not the same thing.

Folate is the umbrella term for the naturally occurring forms of vitamin B9. The name comes from the Latin folium, the leaf. That is no coincidence, because dark green leafy vegetables are among the densest sources. In food, folate is usually present as a so-called polyglutamate, that is with an attached chain the gut has to split off first.

Folic acid is the synthetic, fully oxidised form. It barely occurs in nature. It was developed because it is chemically extraordinarily stable, which makes it easy to put into tablets and into fortified foods. That very stability is its advantage and at the same time the reason for the discussion we are about to have.

5-methyltetrahydrofolate, or 5-MTHF for short, is the form in which folate circulates in the blood and does its actual job. As a supplement it comes as a calcium or sodium salt, often called levomefolate or metafolin on labels.

How big is the difference in the blood? There are measurements for that, and they are clearer than you would expect.

And now you know why the question folate or folic acid has no simple yes or no answer.

Methylation, told simply: your body and its methyl groups

Methylation sounds like advanced chemistry class. It is actually one of the simplest movements your body knows.

Picture a methyl group as a tiny sticker. One carbon atom with three hydrogens, nothing more. Your body sticks this label onto other molecules and changes their behaviour with it. A gene is turned down. A messenger substance is broken down. A nerve building block is completed. A cell membrane gets its component.

The central sticker dispenser is called S-adenosylmethionine, SAM for short. It is made from the amino acid methionine. And methionine arises, among other routes, when homocysteine is given a methyl group as a gift.

Where does this methyl group come from? That is exactly where folate enters. 5-MTHF is the carrier that delivers it. Vitamin B12 is the handle for the handover, and without it the handover cannot take place.

MTHFR stands for methylenetetrahydrofolate reductase. The enzyme converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate. After that the methyl group is ready to be handed over.

This enzyme does not work alone. It needs riboflavin, that is vitamin B2, in the form of FAD as a firm cofactor. And here it gets interesting, because the C677T variant mainly makes the enzyme thermolabile and more prone to losing its cofactor.

And now you know why I rarely talk about a single preparation with this topic and almost always about the interplay.

MTHFR C677T and A1298C: what the numbers give, and what they do not

Now the part where I risk taking away an explanation you have grown fond of. I am writing it anyway, because I do not want to hand you a text that only confirms what is in your browser history.

There are two variants that keep showing up online. C677T sits in the catalytic part of the enzyme and makes it more heat sensitive. A1298C sits in the regulatory part and has considerably less influence on measured enzyme activity. For A1298C on its own, the data on clinical consequences are thin so far.

How big is the effect on hard endpoints? There is a very large analysis for that, and its result is remarkably unspectacular.

From this overall picture the American professional body for human genetics drew a clear consequence.

And now you know why in consultations I rarely ask about the gene test and almost always about nutrition, medication and the homocysteine value.

Unmetabolised folic acid: the open question that has to stay honestly open

Now to the argument that comes up most often in the discussion around 5-MTHF. It is better than its reputation in both directions: not as harmless as the critics of the criticism claim, and not as dangerous as the marketing for expensive alternatives suggests.

Folic acid has to be reduced in the gut and the liver via the enzyme DHFR before it can enter the folate cycle. In humans this enzyme works comparatively slowly. If a lot of folic acid arrives at once, the capacity is exceeded. Part of it then appears unchanged in the blood.

That is exactly what the cross-over study with 24 adults showed: after folic acid, unchanged folic acid in plasma rose temporarily, and after 5-MTHF it did not. And it can also be measured where it is particularly sensitive.

What follows from this for health? Here what has been measured separates cleanly from what is being assumed.

What is measured: unmetabolised folic acid can be detected in blood and in breast milk, and its amount depends on dose and form.

What is assumed and discussed: a connection with immune functions, with inflammatory processes and with cancer risk. For the immunological part there is an exciting paper, explicitly formulated as a hypothesis.

And what about the cancer question that comes up most often in forums? For that we have perhaps the most important analysis in the whole field.

And now you know why on this point I neither reassure nor dramatise.

Homocysteine instead of a gene test: the marker that shows what your metabolism is doing

If you take one practical thing away from this text, let it be this: there is a blood value that tells you more about your methylation metabolism than any gene test. It is called homocysteine.

Homocysteine is an amino acid that arises as an intermediate product in the methylation cycle. When there is enough folate, B12 and B6 and the enzymes are running, it is processed onwards briskly. When there is sand somewhere in the system, it backs up.

That makes it something rare in laboratory medicine: a functional marker. It does not measure how much of a substance is floating in the blood, but whether a metabolic reaction is actually taking place.

The great advantage of a functional marker: you can measure it again after an intervention. And for that there is even a fairly precise dose response curve.

Now the uncomfortable follow-up question: if folic acid was able to lower homocysteine so dependably in these studies, does it also prevent heart attacks? The answer is sobering and instructive at the same time.

One exception is interesting enough to mention, because it brings genetics back into play.

And now you know why I would rather invest in homocysteine, folate and B12 status than in a gene test whose result will never change again in your life.

Pregnancy: the clearest indication in the whole field

There are not many places in nutritional medicine where the data are this unambiguous. This is one of them.

The neural tube is the structure from which brain and spinal cord develop. It closes between the 22nd and the 28th day after fertilisation. At that point many women do not yet know that they are pregnant. That is where the whole logic of the time window sits.

How strongly this plays out at population level is shown by an American analysis after the introduction of mandatory flour fortification.

And now you know why, for all my scepticism about supplement trends, I am very clear on this one point.

When folate masks a B12 deficiency, and where it gets genuinely critical

Now comes the section I consider the most important. Not because it is spectacular, but because this is where harm can actually arise.

A vitamin B12 deficiency classically shows up first in the blood count. The red blood cells become too large, because cell division stalls. That is a visible warning signal which used to lead to the diagnosis.

And here something treacherous happens. Folate can bypass this part of the problem. The blood count can look unremarkable again, while the second part of the B12 deficiency carries on unchecked: damage to the nerve sheaths in the spinal cord and in the peripheral nerves. If it persists long enough, this damage can remain.

How seriously this point is taken can be seen from which effect the European authority selected as decisive for the safety limit.

The methotrexate point is worth a closer look, because it is at the same time the finest example of the difference between covering a requirement and a therapeutic application.

That medications can change folate status is, incidentally, well documented.

And now you know why the question about the medication list matters more with this topic than the question about the genotype.

The four lenses: why folate plays along everywhere at once

In clinical psychoneuroimmunology we look at a symptom through four lenses. With folate that is not a detour, it follows directly from the biochemistry: a molecule that distributes methyl groups inevitably turns up wherever something is labelled, built or switched off.

These four lenses explain why folate turns up in such different contexts: in antenatal care, in blood formation, in psychiatry, in cardiology, in oncology. Not because it is a cure-all. But because a molecule involved in the basic mechanics of cell division and gene regulation can make itself felt in many places when it runs short.

Real food first, and why topping up is still more often justified today

Before we come to the levers, one sentence I repeat with every nutrient topic: supply from real food of good origin is always the first choice.

There is a concrete reason for that. A food never delivers folate on its own. Lentils bring fibre, protein, potassium and magnesium along with it. Liver brings B12, iron and choline along with it, so several cofactors of the methylation cycle in one bite. No capsule rebuilds that matrix.

The most folate rich foods are quickly listed: dark green leafy vegetables, spinach, lamb's lettuce, rocket, kale, plus pulses, broccoli, Brussels sprouts, asparagus, beetroot, avocado, wheat germ and, by far the densest, liver from good husbandry. Liver comes with an important caveat: it contains a great deal of vitamin A. In pregnancy and when trying to conceive, official advice is against it, especially in the first weeks. If you are pregnant or would like to be, you are better off covering folate through leafy greens and pulses. Folate is, however, sensitive to heat, light and long soaking. With long cooking a considerable part is lost, and some stays behind in the cooking water.

So why is food still not always enough? That has to do with changed conditions, not with a passing fashion.

And now you know why the answer is neither "just take a supplement" nor "just eat better", but somewhere in between, and should be decided individually.

Three levers you can put in place today

No protocol, no weekly plans, no brands. Just three things that are in your hands.

One point that is missing from almost every guide: a low folate value is not just a number you top up. It can be a pointer to something underneath. The most common are impaired absorption in the small intestine, for example in coeliac disease or inflammatory bowel disease, a state after stomach or bowel surgery, and a regularly high alcohol intake.

So if a folate deficiency is found in you, the question of why it arose always belongs with it. A supplement that lifts the value again without that question having been asked can keep the actual cause invisible for months. The same applies to enlarged red blood cells: they can come from B12 or folate, but also from other conditions, and therefore belong in medical work-up rather than in self-treatment.

And now you know why the most honest answer to "I have MTHFR, what should I take" begins with two counter-questions: what do you eat, and which medications are you taking?

Common questions about folate, folic acid and MTHFR

How this topic connects to the others

Folate rarely stands alone. When you notice that one building block does not explain the story, these paths lead further.